Stock Analyses

Model-driven valuations for thousands of US-listed stocks, built from SEC EDGAR filings. Click any card to see the full analysis.

All sectors 6,479 Financial Services 1,900 Healthcare 1,116 Technology 1,079 Industrials 668 Consumer Cyclical 490 Basic Materials 337 Consumer Defensive 248 Communication Services 213 Utilities 183 Energy 165 Real Estate 80
Clear
6,990 stocks · page 2 of 117
Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
ACDC
ProFrac Holding Corp.
Deeply undervalued
Energy
Price$5.17
Model IV$22.20
P/IV0.28
Discount 77% Return to IV: +329.4%
Owner yield 16.0% 10-yr IRR 29.5% · moderate
Market implies -13.5%/yr vs model +8.0% · below model
ACEL
Accel Entertainment, Inc.
Deeply undervalued
Communication Services
Price$11.53
Model IV$17.47
P/IV0.68
Discount 34% Return to IV: +51.6%
Owner yield 5.6% 10-yr IRR 16.7% · grower
Market implies +5.8%/yr vs model +15.9% · below model
ACET
Adicet Bio, Inc.
Valuation N/A
Healthcare
Price$9.18
Model IV—
P/IV—
ACFN
ACORN ENERGY, INC.
Deeply overvalued
Industrials
Price$22.21
Model IV$11.21
P/IV1.52
Premium +98% Return to IV: -49.5%
Market implies +14.8%/yr vs model +11.7% · above model
ACGC
ACP Holdings Acquisition Corp.
Valuation N/A
Financial Services
Price$10.04
Model IV—
P/IV—
ACGCU
ACP Holdings Acquisition Corp.
Valuation N/A
Financial Services
Price$10.12
Model IV—
P/IV—
ACGL
ARCH CAPITAL GROUP LTD.
Deeply undervalued
Financial Services
Price$96.89
Model IV$141.46
P/IV0.63
Discount 32% Return to IV: +46.0%
ACGLN
ARCH CAPITAL GROUP LTD.
Deeply undervalued
Financial Services
Price$15.11
Model IV$141.46
P/IV0.12
Discount 89% Return to IV: +836.2%
ACGLO
ARCH CAPITAL GROUP LTD.
Deeply undervalued
Financial Services
Price$18.68
Model IV$141.46
P/IV0.14
Discount 87% Return to IV: +657.3%
ACH
ACCENDRA HEALTH INC/VA/
Valuation N/A
Industrials
Price$0.89
Model IV—
P/IV—
Market implies -50.0%/yr vs model +2.0% · below model
ACHC
Acadia Healthcare Company, Inc.
Deeply undervalued
Healthcare
Price$28.33
Model IV$43.21
P/IV0.54
Discount 34% Return to IV: +52.5%
Market implies +1.0%/yr vs model +8.0% · below model
ACHR
Archer Aviation Inc.
Valuation N/A
Industrials
Price$5.26
Model IV—
P/IV—
Market implies +150.0%/yr vs model +15.0% · above model
ACHV
ACHIEVE LIFE SCIENCES, INC.
Valuation N/A
Healthcare
Price$7.98
Model IV—
P/IV—
ACI
Albertsons Companies, Inc.
Valuation N/A
Consumer Defensive
Price$12.35
Model IV—
P/IV—
Owner yield 9.4% 10-yr IRR 15.9% · steady
Market implies -3.9%/yr vs model +4.1% · below model
ACIC
AMERICAN COASTAL INSURANCE Corp
Deeply undervalued
Financial Services
Price$9.18
Model IV$14.27
P/IV0.73
Discount 36% Return to IV: +55.4%
ACIU
AC Immune SA
Valuation N/A
Healthcare
Price$2.63
Model IV—
P/IV—
ACIW
ACI WORLDWIDE, INC.
Fairly valued
Technology
Price$50.27
Model IV$51.34
P/IV0.85
Discount 2% Return to IV: +2.1%
Owner yield 5.1% 10-yr IRR 12.4% · moderate
Market implies +8.6%/yr vs model +11.2% · in line
ACLS
AXCELIS TECHNOLOGIES INC
Deeply overvalued
Industrials
Price$109.32
Model IV$30.66
P/IV4.91
Premium +257% Return to IV: -72.0%
Owner yield 3.6% 10-yr IRR 5.2% · moderate
Market implies +25.9%/yr vs model +8.0% · above model
ACM
AECOM
Deeply undervalued
Industrials
Price$61.99
Model IV$91.13
P/IV0.76
Discount 32% Return to IV: +47.0%
Owner yield 8.0% 10-yr IRR 16.7% · moderate
Market implies +1.4%/yr vs model +8.1% · below model
ACMR
ACM Research, Inc.
Valuation N/A
Industrials
Price$68.51
Model IV—
P/IV—
Market implies +30.6%/yr vs model +36.5% · below model
ACN
Accenture plc
Deeply undervalued
Technology
Price$181.29
Model IV$331.70
P/IV0.56
Discount 45% Return to IV: +83.0%
Owner yield 8.3% 10-yr IRR 18.8% · moderate
Market implies 0.0%/yr vs model +10.0% · below model
ACNB
ACNB CORP
Deeply overvalued
Financial Services
Price$64.57
Model IV$46.70
P/IV1.16
Premium +38% Return to IV: -27.7%
ACNT
ASCENT INDUSTRIES CO.
Overvalued
Basic Materials
Price$14.75
Model IV$12.11
P/IV1.12
Premium +22% Return to IV: -17.9%
Owner yield 7.4% 10-yr IRR 8.9% · steady
Market implies -2.2%/yr vs model +0.0% · in line
ACOG
Alpha Cognition Inc.
Valuation N/A
Healthcare
Price$8.83
Model IV—
P/IV—
Market implies +29.9%/yr vs model +15.0% · above model
ACON
Aclarion, Inc.
Valuation N/A
Healthcare
Price$2.52
Model IV—
P/IV—
Market implies +31.6%/yr vs model +5.9% · above model
ACONW
Aclarion, Inc.
Deeply undervalued
Healthcare
Price$0.03
Model IV$0.06
P/IV0.43
Discount 57% Return to IV: +134.4%
Market implies -25.0%/yr vs model +5.9% · below model
ACP
abrdn Income Credit Strategies Fund
Valuation N/A
Unknown
Price$4.65
Model IV—
P/IV—
ACR
ACRES Commercial Realty Corp.
Valuation N/A
Financial Services
Price$13.36
Model IV—
P/IV—
ACRE
Ares Commercial Real Estate Corp
Deeply undervalued
Financial Services
Price$4.38
Model IV$6.70
P/IV0.74
Discount 35% Return to IV: +52.9%
ACRS
Aclaris Therapeutics, Inc.
Valuation N/A
Healthcare
Price$5.50
Model IV—
P/IV—
Market implies +36.5%/yr vs model +3.7% · above model
ACRV
Acrivon Therapeutics, Inc.
Valuation N/A
Healthcare
Price$1.85
Model IV—
P/IV—
ACT
Enact Holdings, Inc.
Deeply undervalued
Financial Services
Price$48.45
Model IV$128.60
P/IV0.33
Discount 62% Return to IV: +165.4%
Market implies -7.0%/yr vs model +6.3% · below model
ACTG
ACACIA RESEARCH CORP
Deeply overvalued
Financial Services
Price$4.57
Model IV$0.99
P/IV2.54
Premium +360% Return to IV: -78.2%
ACTU
ACTUATE THERAPEUTICS, INC.
Valuation N/A
Healthcare
Price$1.07
Model IV—
P/IV—
ACU
ACME UNITED CORP
Deeply overvalued
Industrials
Price$61.50
Model IV$16.96
P/IV2.49
Premium +263% Return to IV: -72.4%
Owner yield 4.9% 10-yr IRR 5.5% · steady
Market implies +18.0%/yr vs model +3.2% · above model
ACV
Virtus Diversified Income & Convertible Fund
Valuation N/A
Unknown
Price$25.46
Model IV—
P/IV—
ACVA
ACV Auctions Inc.
Deeply overvalued
Technology
Price$10.48
Model IV$1.80
P/IV3.64
Premium +481% Return to IV: -82.8%
Market implies +38.0%/yr vs model +18.1% · above model
ACXP
Acurx Pharmaceuticals, Inc.
Valuation N/A
Healthcare
Price$1.39
Model IV—
P/IV—
AD
ARRAY DIGITAL INFRASTRUCTURE, INC.
Deeply undervalued
Communication Services
Price$38.12
Model IV$410.53
P/IV0.12
Discount 91% Return to IV: +976.9%
Owner yield 18.7% 10-yr IRR 39.9% · grower
Market implies -13.1%/yr vs model +25.0% · below model
ADAC
American Drive Acquisition Co
Valuation N/A
Financial Services
Price$10.09
Model IV—
P/IV—
ADACU
American Drive Acquisition Co
Valuation N/A
Financial Services
Price$10.23
Model IV—
P/IV—
ADACW
American Drive Acquisition Co
Valuation N/A
Financial Services
Price$0.30
Model IV—
P/IV—
ADAG
Adagene Inc.
Valuation N/A
Healthcare
Price$3.31
Model IV—
P/IV—
Market implies +44.7%/yr vs model +2.0% · above model
ADAM
ADAMAS TRUST, INC.
Fairly valued
Financial Services
Price$8.91
Model IV$8.31
P/IV1.11
Premium +7% Return to IV: -6.7%
ADAMG
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services
Price$25.29
Model IV$12.17
P/IV2.07
Premium +108% Return to IV: -51.9%
ADAMH
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services
Price$25.65
Model IV$12.17
P/IV2.11
Premium +111% Return to IV: -52.5%
ADAMI
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services
Price$25.00
Model IV$12.17
P/IV2.09
Premium +105% Return to IV: -51.3%
ADAML
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services
Price$25.03
Model IV$12.17
P/IV1.99
Premium +106% Return to IV: -51.4%
ADAMM
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services
Price$25.67
Model IV$12.17
P/IV2.08
Premium +111% Return to IV: -52.6%
ADAMN
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services
Price$24.68
Model IV$12.17
P/IV1.91
Premium +103% Return to IV: -50.7%
ADAMO
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services
Price$25.23
Model IV$12.17
P/IV2.08
Premium +107% Return to IV: -51.8%
ADAMZ
ADAMAS TRUST, INC.
Deeply overvalued
Financial Services
Price$17.95
Model IV$11.32
P/IV1.62
Premium +59% Return to IV: -36.9%
ADBE
ADOBE INC.
Deeply undervalued
Technology
Price$248.92
Model IV$651.52
P/IV0.40
Discount 62% Return to IV: +161.7%
Owner yield 7.7% 10-yr IRR 21.1% · grower
Market implies -0.7%/yr vs model +14.1% · below model
ADC
AGREE REALTY CORP
Undervalued
Financial Services
Price$68.05
Model IV$81.77
P/IV0.91
Discount 17% Return to IV: +20.2%
ADCT
ADC Therapeutics SA
Valuation N/A
Healthcare
Price$1.05
Model IV—
P/IV—
Market implies +11.1%/yr vs model +15.0% · below model
ADEA
Adeia Inc.
Deeply overvalued
Communication Services
Price$24.82
Model IV$10.77
P/IV2.48
Premium +130% Return to IV: -56.6%
Owner yield 6.1% 10-yr IRR 9.9% · steady
Market implies +16.7%/yr vs model +4.6% · above model
ADGM
Adagio Medical Holdings, Inc.
Valuation N/A
Healthcare
Price$0.48
Model IV—
P/IV—
Market implies +40.3%/yr vs model +15.0% · above model
ADI
ANALOG DEVICES INC
Deeply overvalued
Technology
Price$375.72
Model IV$139.94
P/IV2.96
Premium +168% Return to IV: -62.8%
Owner yield 2.0% 10-yr IRR 0.1% · moderate
Market implies +22.9%/yr vs model +11.1% · above model
ADIL
ADIAL PHARMACEUTICALS, INC.
Valuation N/A
Healthcare
Price$4.86
Model IV—
P/IV—
ADM
Archer-Daniels-Midland Co
Deeply undervalued
Consumer Defensive
Price$85.18
Model IV$181.86
P/IV0.44
Discount 53% Return to IV: +113.5%
Owner yield 6.8% 10-yr IRR 12.3% · steady
Market implies -4.2%/yr vs model +5.8% · below model